Legend Biotech Corporation Announces Pricing of Public Offering
Legend Biotech Corporation announced the pricing of an underwritten public offering of 7.7 million American Depositary Shares at $29.35 each, with proceeds expected around $226 million before fees. The offering aims to strengthen the company's financial position to support its leadership in CAR-T cell therapies, notably CARVYKTI® for multiple myelo…